According to the NCI website, anti-PD-1/CTLA-4 bispecific antibody AK104 is a bispecific antibody directed against the human negative immunoregulatory checkpoint receptors programmed cell death protein 1. Check for active clinical trials using this agent. (NCI Thesaurus)